Atlas Trials

Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease

Clinical trial NCT02360527 · COMPLETED

Trial details

NCT number
NCT02360527
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Retinal NeurodegenerationAlzheimer´s DiseaseType 2 Diabetes
Start date
2014-09-01
Primary completion
2015-11-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.